These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 31113827)

  • 1. Insulinoma-Associated-1: From Neuroendocrine Tumor Marker to Cancer Therapeutics.
    Chen C; Notkins AL; Lan MS
    Mol Cancer Res; 2019 Aug; 17(8):1597-1604. PubMed ID: 31113827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulinoma-associated protein 1 (INSM1): a potential biomarker and therapeutic target for neuroendocrine tumors.
    Mahalakshmi B; Baskaran R; Shanmugavadivu M; Nguyen NT; Velmurugan BK
    Cell Oncol (Dordr); 2020 Jun; 43(3):367-376. PubMed ID: 32219703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sonic hedgehog signaling pathway promotes INSM1 transcription factor in neuroendocrine lung cancer.
    Chen C; Breslin MB; Lan MS
    Cell Signal; 2018 Jun; 46():83-91. PubMed ID: 29501727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure, expression, and biological function of INSM1 transcription factor in neuroendocrine differentiation.
    Lan MS; Breslin MB
    FASEB J; 2009 Jul; 23(7):2024-33. PubMed ID: 19246490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Insulinoma-Associated Protein 1 (INSM1) and Orthopedia Homeobox (OTP) in Tumors with Neuroendocrine Differentiation at Rare Sites.
    Roy M; Buehler DG; Zhang R; Schwalbe ML; Baus RM; Salamat MS; Lloyd RV; Rosenbaum JN
    Endocr Pathol; 2019 Mar; 30(1):35-42. PubMed ID: 30523500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INSM1 expression in neuroendocrine tumors in a tertiary care hospital.
    Chandrasekaran K; Sundaram S; Balasubramanian S
    J Cancer Res Ther; 2024 Apr; 20(3):811-816. PubMed ID: 39023587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulinoma-associated protein 1 (INSM1) is a robust marker for identifying and grading pancreatic neuroendocrine tumors.
    Kim D; Viswanathan K; Goyal A; Rao R
    Cancer Cytopathol; 2020 Apr; 128(4):269-277. PubMed ID: 31977134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulinoma-associated protein 1 is a sensitive and specific marker of neuroendocrine lung neoplasms in cytology specimens.
    Doxtader EE; Mukhopadhyay S
    Cancer Cytopathol; 2018 Apr; 126(4):243-252. PubMed ID: 29360191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulinoma-associated protein 1 immunostaining on cytology specimens: an institutional experience.
    Rodriguez EF; Fite JJ; Chowsilpa S; Maleki Z
    Hum Pathol; 2019 Mar; 85():128-135. PubMed ID: 30502379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5'-Iodotubercidin represses
    Chen C; Breslin MB; Guidry JJ; Lan MS
    J Biol Chem; 2019 Apr; 294(14):5456-5465. PubMed ID: 30755485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. INSM1 increases N-myc stability and oncogenesis via a positive-feedback loop in neuroblastoma.
    Chen C; Breslin MB; Lan MS
    Oncotarget; 2015 Nov; 6(34):36700-12. PubMed ID: 26456864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulinoma-associated protein 1 is a sensitive and specific marker for lung neuroendocrine tumors in cytologic and surgical specimens.
    Viswanathan K; Siddiqui MT; Borczuk AC
    J Am Soc Cytopathol; 2019; 8(6):299-308. PubMed ID: 31345782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosensitivity and specificity of insulinoma-associated protein 1 (INSM1) for neuroendocrine neoplasms of the uterine cervix.
    Kuji S; Endo A; Kubota M; Uekawa A; Kawakami F; Mikami Y; Koike J; Suzuki N
    J Gynecol Oncol; 2023 Jan; 34(1):e1. PubMed ID: 36245222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and significance of INSM1 and SOX11 in pancreatic neuroendocrine tumor and solid pseudopapillary neoplasm].
    Cao Z; Cen HB; Zhao JH; Mei J; Qin LZ; Liao W; Ao QL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):575-581. PubMed ID: 37534634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-specific promoter-driven adenoviral therapy for insulinoma.
    Tseng AW; Chen C; Breslin MB; Lan MS
    Cell Oncol (Dordr); 2016 Jun; 39(3):279-86. PubMed ID: 26902080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of insulinoma-associated protein 1 in non-small cell lung cancers: a diagnostic pitfall for neuroendocrine tumors.
    Wang M; Abi-Raad R; Baldassarri R; Adeniran AJ; Cai G
    Hum Pathol; 2021 Sep; 115():104-111. PubMed ID: 34216697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulinoma-associated protein 1 immunostaining for various types of neuroendocrine tumors on FNA smears.
    Hou T; Gan Q; Joseph CT; Sun X; Gong Y
    Cancer Cytopathol; 2020 Oct; 128(10):725-732. PubMed ID: 32573984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulinoma-associated protein 1 expression in pancreatic neuroendocrine tumours in endoscopic ultrasound-guided fine-needle aspiration cytology: An analysis of 14 patients.
    Takase Y; Naito Y; Okabe Y; Ishida Y; Yamaguchi T; Abe H; Murata K; Ito T; Tanigawa M; Kawahara A; Yano H; Akiba J
    Cytopathology; 2019 Mar; 30(2):194-200. PubMed ID: 30290028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor.
    Tanigawa M; Nakayama M; Taira T; Hattori S; Mihara Y; Kondo R; Kusano H; Nakamura K; Abe Y; Ishida Y; Okabe Y; Hisaka T; Okuda K; Fujino K; Ito T; Kawahara A; Naito Y; Yamaguchi R; Akiba J; Akagi Y; Yano H
    Med Mol Morphol; 2018 Mar; 51(1):32-40. PubMed ID: 28849340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A promoter-driven assay for INSM1-associated signaling pathway in neuroblastoma.
    Chen C; Lan MS
    Cell Signal; 2020 Dec; 76():109785. PubMed ID: 32966884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.